AdvisorShares Investments LLC Has $673,000 Stock Position in COMPASS Pathways plc (NASDAQ:CMPS)

AdvisorShares Investments LLC lifted its stake in COMPASS Pathways plc (NASDAQ:CMPSGet Rating) by 55.4% during the first quarter, Holdings Channel.com reports. The fund owned 52,228 shares of the company’s stock after buying an additional 18,620 shares during the period. AdvisorShares Investments LLC’s holdings in COMPASS Pathways were worth $673,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of CMPS. Ghost Tree Capital LLC grew its holdings in COMPASS Pathways by 110.0% during the fourth quarter. Ghost Tree Capital LLC now owns 210,000 shares of the company’s stock worth $4,641,000 after purchasing an additional 110,000 shares during the period. PFS Investments Inc. grew its holdings in COMPASS Pathways by 90.0% during the fourth quarter. PFS Investments Inc. now owns 30,812 shares of the company’s stock worth $681,000 after purchasing an additional 14,592 shares during the period. Oasis Management Co Ltd. grew its holdings in COMPASS Pathways by 31.7% during the fourth quarter. Oasis Management Co Ltd. now owns 207,911 shares of the company’s stock worth $4,595,000 after purchasing an additional 50,000 shares during the period. Advanced Research Investment Solutions LLC bought a new position in COMPASS Pathways during the fourth quarter worth about $110,000. Finally, Virtus ETF Advisers LLC grew its holdings in COMPASS Pathways by 27.1% during the fourth quarter. Virtus ETF Advisers LLC now owns 6,913 shares of the company’s stock worth $153,000 after purchasing an additional 1,474 shares during the period. Institutional investors and hedge funds own 17.86% of the company’s stock.

COMPASS Pathways Trading Up 14.7 %

Shares of CMPS stock opened at $20.07 on Friday. The stock has a 50 day simple moving average of $11.95 and a 200 day simple moving average of $12.21. COMPASS Pathways plc has a 1 year low of $6.54 and a 1 year high of $49.51.

COMPASS Pathways (NASDAQ:CMPSGet Rating) last issued its quarterly earnings results on Tuesday, May 10th. The company reported ($0.50) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.68) by $0.18. During the same period in the prior year, the firm earned ($0.35) earnings per share. On average, equities research analysts expect that COMPASS Pathways plc will post -2.45 earnings per share for the current year.

Wall Street Analyst Weigh In

CMPS has been the subject of a number of research analyst reports. Citigroup reduced their price objective on COMPASS Pathways from $49.00 to $46.00 and set a “buy” rating for the company in a report on Friday. Cantor Fitzgerald reduced their price objective on COMPASS Pathways from $58.00 to $35.00 in a report on Friday. Six equities research analysts have rated the stock with a buy rating, According to MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of $74.33.

COMPASS Pathways Profile

(Get Rating)

COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder.

See Also

Want to see what other hedge funds are holding CMPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for COMPASS Pathways plc (NASDAQ:CMPSGet Rating).

Institutional Ownership by Quarter for COMPASS Pathways (NASDAQ:CMPS)

Receive News & Ratings for COMPASS Pathways Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for COMPASS Pathways and related companies with MarketBeat.com's FREE daily email newsletter.